"Hypertension, Pulmonary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Descriptor ID |
D006976
|
| MeSH Number(s) |
C08.381.423
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hypertension, Pulmonary".
Below are MeSH descriptors whose meaning is more specific than "Hypertension, Pulmonary".
This graph shows the total number of publications written about "Hypertension, Pulmonary" by people in this website by year, and whether "Hypertension, Pulmonary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 0 | 2 |
| 1999 | 4 | 1 | 5 |
| 2000 | 2 | 3 | 5 |
| 2001 | 4 | 1 | 5 |
| 2002 | 2 | 1 | 3 |
| 2003 | 5 | 1 | 6 |
| 2004 | 5 | 1 | 6 |
| 2005 | 6 | 1 | 7 |
| 2006 | 7 | 0 | 7 |
| 2007 | 2 | 3 | 5 |
| 2008 | 3 | 1 | 4 |
| 2009 | 6 | 0 | 6 |
| 2010 | 8 | 3 | 11 |
| 2011 | 9 | 7 | 16 |
| 2012 | 10 | 5 | 15 |
| 2013 | 7 | 2 | 9 |
| 2014 | 12 | 5 | 17 |
| 2015 | 8 | 4 | 12 |
| 2016 | 10 | 2 | 12 |
| 2017 | 12 | 1 | 13 |
| 2018 | 3 | 6 | 9 |
| 2019 | 13 | 3 | 16 |
| 2020 | 20 | 1 | 21 |
| 2021 | 17 | 4 | 21 |
| 2022 | 9 | 0 | 9 |
| 2023 | 14 | 2 | 16 |
| 2024 | 5 | 8 | 13 |
| 2025 | 11 | 0 | 11 |
| 2026 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypertension, Pulmonary" by people in Profiles.
-
Clonal Hematopoiesis (CHIP) in Pulmonary Embolism and CTEPH: Evidence, Mechanisms, and Risk Stratification. Int J Mol Sci. 2026 Mar 18; 27(6).
-
Alternative Polyadenylation Signatures Distinguish Maladaptive Right Ventricular Remodeling in Pulmonary Hypertension: Implications for RNA-Based Diagnostics and Therapeutics. Br J Biomed Sci. 2026; 83:15687.
-
Morning Larks and Night Owls: Considering Chronotype in Evaluation of Patients with Pulmonary Hypertension. Ann Am Thorac Soc. 2026 Feb 01; 23(2):261-271.
-
Incident Pulmonary Hypertension and Its Risk Factors in CKD. Clin J Am Soc Nephrol. 2026 Apr 01; 21(4):544-552.
-
Adrenomedullin overexpression protects mice from experimental bronchopulmonary dysplasia and associated pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2025 Dec 01; 329(6):L677-L685.
-
Inhibition of BMPER Mitigates Pulmonary Hypertension by Modulating LRP1-YAP Interaction in Smooth Muscle Cells. Arterioscler Thromb Vasc Biol. 2025 Nov; 45(11):2037-2052.
-
Pulmonary Hypertension Associated With Interstitial Lung Diseases. Chest. 2026 Jan; 169(1):220-229.
-
Outcomes of Extracorporeal Membrane Oxygenation in Patients with COVID-19 and Pulmonary Hypertension: An ELSO Registry Analysis. J Cardiothorac Vasc Anesth. 2026 Jan; 40(1):222-228.
-
Procedural Variation May Contribute to 6-Minute Walk Distance Variability in Real-World Pediatric Pulmonary Arterial Hypertension Study. AAPS J. 2025 06 27; 27(5):114.
-
Echo-Derived Right Ventricular Strain Identifies Pulmonary Hypertension in Pediatric Ventricular Assist Device Patients. ASAIO J. 2026 Apr 01; 72(4):348-353.